Axel Kirsch, PhD
Chairman Advisory Board
Dr. Axel Kirsch is an internationally recognized pioneer in the field of perio-implant-prosthetics.
Over the past more than 30 years, Dr. Kirsch’s experimental and clinical experience has resulted in the development of the IMZ Implant System, and since 1995, the Camlog Implant System. Dr. Kirsch and his interdisciplinary team of experts developed and tested the Camlog Implant system both experimentally and clinically.
His current clinical research is centered on the field of hard- and soft-tissue management for reliable implant-prosthetic rehabilitations. Since 1974, Dr. Kirsch has given training courses and lectures throughout the world on the IMZ Implant System, on the Camlog Implant System, on preprosthetic surgery and on perio-implant-prosthetics; has published multiple scientific and clinical articles and holds academic appointments at the following institutions: Adjunct Professor at Boston University, Goldman School of Dental Medicine, Center of Implantology; Associate Professor at Nippon Dental University, Department of Crown and Bridge Prosthedontics; Visiting Professor, at the UCLA, Department for Oral and Maxillofacial Surgery, Los Angeles, CA, U.S.A. and Associate Professor at the University of Belgrade, Faculty of Stomatology.
Ulrich Lohmann, LL.M
Dr. Lohmann is a partner in the law firm v. Boetticher Hasse Lohmann (www.boetticher.com), resident in the Frankfurt office. Dr. Lohmann specializes in advising on international corporate and technology transactions and on cross-border dispute resolution. He has acted as arbitrator and business mediator in domestic and cross-border proceedings and as member of the boards of privately and publicly held companies.
Carlos Guzman, PhD
Scientific Advisor Immunology
Prof. Dr. med., Carlos Guzman, PhD has studied medicine in Argentina and Italy and recieved in 1981 his MD from the University of Rasario, School of Medicine and his PhD in 1988 from the University of Genua, Italy. After specialization in microbiology at the University of Genua he obtained a position at the GBF (National Research Center for Biotechnology) in Braunschweig, Germany as head of the Bordetella research laboratory and in the following course he became head of the vaccine research group, Department of Microbial Pathogenesis and Vaccine Reseach. In parallel to his activities at the GBF he was assistant professor at the Department of Medical Microbiology and Hospital Epidemiology, at the Medical School Hanover. In 2005 he became APL-Professor of Medical Microbiology (Personal Chair) at the Hanover Medical School. Since 2005 he is the head of the Department of Vaccinology at the HZI-Helmholtz Centre for Infection Research, Braunschweig. Prof. Guzman is member of numerous scientific societies and shares the editorial board of several high ranking scientific journals. He is engaged as consultant of several international societies and of certain Biotech-companies. His publications in peer-reviewed scientific journals exceed the number of 100. His work is focused in the vaccinology field, with the specific goal of establishing tools & strategies to prevent and treat infectious diseases. This major aim is achieved by pursuing the following specific objectives: (i) understand the underlying mechanisms of host response to infection and vaccination, (ii) discover immune modulators, (iii) generate delivery systems for antigen, DNA and therapeutic molecules, (iv) establish experimental models based on humanized mice for vaccine testing, and (v) develop and test vaccine candidates against specific diseases.
Ernst Leidinger, PhD
Scientific Advisor Veterinary Medicine
Ernst Leidinger has studied veterinary medicine at the University of Vienna. During his studies he was engaged as demonstrator and assistant at the Institute of Anatomy. After finishing his diploma study he was assistant professor at the Institute of Medicinal Chemistry from 1986 to 1995 of the Veterinary University in Vienna. His PhD thesis covered the production of monoclonal antibodies against synthetic peptide antigens. In 1995 Ernst Leidinger founded the veterinary diagnosis laboratory „Invitro“ where he is the CEO in collaboration with his wife Dr. Judith Leidinger. Since 1995 he is a veterinary specialist for clinical laboratory diagnosis and member of the jury in this field.
In 2005 he became “Diplomat of the European College of Veterinary Clinical Pathology” (ECVCP).
Dr. Leidinger has numerous publications in his field and is an asked lecturer about clinical diagnosis.
Robert Mader, PhD
Scientific Advisor for Oncology
Prof. Dr. Robert Mader was trained in chemistry at the Technical University of Vienna where he received his PhD in biochemistry in 1986. He then moved to the medical faculty of the University of Vienna to establish a science focus on tumour pharmacology in the Division of Oncology. In 1997, he held his habilitation for the field "Experimental Oncology“. His present position is Programme Director for Molecular Pharmacology at the Department of Medicine I, Clinical Division of Oncology at the Medical University of Vienna and Director for Translational Research. Dr. Mader has obtained additional qualifications in project management, quality control in Biotechnology, GCP, and Medical Writing. Since 2005 he is member of the board of CESAR (Central European Society for Anticancer Research) and was vice-chairmen and chairmen director for the working group "Pharmacology in Oncology and Hematology". From 2003 - 2009, he was heading the task force “Tumorbank of the ABCSG (Austrian Breast and Colorectal Cancer Study Group)”, which represents the largest clinical study group in Austria. Since 2011, he serves as coordinator of "CECOG Translational" (a translational research initiative of the Central European Cooperative Oncology Group).
His scientific focus is tumour pharmacology and experimental therapy in pre-clinical and clinical studies covering more than 100 publications and book contributions. He was awarded with several distinct honours by different scientific societies.
Christoph Herwig, PhD
Scientific Advisor for Biochemical Egineering
Professor Herwig entered Biotechnology with studies in process engineering at the RWTH Aachen. Subsequently he worked in the industry, responsible for the manufacturing plant design for the production of basic chemicals. Back in academia, his PhD thesis at the EPF Lausanne dealt with bridging the gap between process development and process engineering for biotechnological processes. After his PhD he worked in biopharmaceutical industry in Switzerland. In 2008, he was appointed full professor for Biochemical Engineering at the Vienna University of Technology.
Jaroslav Michalek, PhD
Scientific Advisor for Cell Therapy and Immunotherapy
Jaroslav Michalek obtained his Ph.D. degree in 1999. In 2003, he became an associate professor at the Masaryk University, Brno, Czech Republic and visiting assistant professor at the University of Texas Southwestern Medical Center, Dallas, TX, U.S.A. In 2007, he became a full professor at the Masaryk University, Brno, Czech Republic. He is now Professor of Pediatrics at the Dept. of Pediatrics, University Hospital Brno, Brno, Czech Republic, the Head Research Consultant at the Advanced Cell Immunotherapy Unit, Masaryk University and the President of International Consortium for Cell Therapy and Immunotherapy and the CEO of Cellthera, Ltd.